@article{e37902db91154385ab81d85a73279930,
title = "Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”",
keywords = "biological product, corticosteroid, mepolizumab, age, biological therapy, body mass, disease exacerbation, disease registry, drug efficacy, drug response, drug use, human, Letter, people by smoking status, personalized medicine, phenotype, prognosis, severe asthma, sex, sinonasal polyp",
author = "W. Chen and L. Bjermer and M.E. Wechsler and D.B. Price",
year = "2024",
doi = "10.1016/j.jaip.2023.12.008",
language = "English",
volume = "12",
pages = "536--539",
journal = "Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "Elsevier",
number = "2",
}
